ClinicalTrials.gg
Active, not recruitingNCT06345690Updated May 12, 2026

VIA Disc NP Registry 3.0

An observational study in Discogenic Pain, Back Pain and Back Pain, Low, sponsored by VIVEX Biologics, Inc.. Active, not recruiting at 24 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-12.

Primary conditionLow Back PainRegistry: Back PainReclassifiedWhy we changed it
Registry
Back Pain — the first condition term the registry derived for this study.
ClinicalTrials.gg
Low Back Pain
Why
  1. The study's listed conditions name Low Back Pain, a narrower term within Back Pain.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by VIVEX Biologics, Inc. · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 712 studies in Low Back Pain with a site in United States — 100 open to participants now, 126 under way, 3 of them phase 3. Low Back Pain · United States.

Planned enrollment
9th of 85
500 · median 90
Started
2024
with 31 others
Observational
87 of 712
19 open now
Primary completion
2027-01
later than 46 of 125 live
Registered
617th of 712
by date

Among the 712 studies in Low Back Pain with a site in United States, this one is the 9th largest by planned enrollment of the 85 observational ones that give a count, is one of 32 that started in 2024, is one of 87 observational ones, reaches primary completion later than 46 of the 125 other live ones, and was the 617th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

100 of the 712 studies in Low Back Pain with a site in United States are open now. Recruiting first, the newest first:

95 more — sign in →

All 100 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 712 studies in Low Back Pain with a site in United States, or all of them as a file.
02

Study summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Read the detailed description

The Registry is intended to collect data for patients having received treatment with VIA Disc NP.

03

Conditions studied

  • Discogenic Pain
  • Back Pain
  • Back Pain, Low

Browse trials for

Keywords

  • Back Pain
04

In context

Low Back Pain Reclassified

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

This study's planned enrollment of 500 is above the median of 100 across 484 observational studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

VIVEX Biologics, Inc. is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Compared within Low Back Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Back Pain. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants diagnosed with and treated for back pain.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Willing to sign the and deemed capable of complying with the requirements of the study protocol
  2. 18 years of age or older
  3. Literate, able to speak and read English, and able to complete questionnaires independently
  4. Subject received a VIA Disc NP injection with 1 or more levels within 90 days of the baseline visit.

Exclusion criteria

Exclusion Criteria:

  1. Participant did not receive VIA Disc NP injection
  2. Participant is pregnant (self-reported, no special study pregnancy testing needed).
  3. Any as noted in the VIA Disc NP Instructions for Use
  4. Previous treatment with VIA Disc NP
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

06

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
500 participants (estimated)
Target follow-up
12 Months
Patient registry
Yes

Groups and cohorts

  • VIA Disc NP

    Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment

    Other: VIA Disc NP

Interventions

  • OtherVIA Disc NP

    VIA Disc NP - Allograft tissue injection

07

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    Change in Numeric Rating Scale (NRS) scores. Eleven point pain scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable).

    Time frame: 1, 3, 6, & 12 months

  2. Oswestry Disability Index (ODI)

    Change in scores from Oswestry Disability Index (ODI). An index comprising of ten categories of function to quantify disability due to back pain.

    Time frame: 1, 3, 6, & 12 months

  3. Patient Satisfaction

    Patient reported assessment of treatment regarding their experience with the procedure. Four different responses, which range from Not at all satisfied (worst) to Extremely Satisfied (best).

    Time frame: 1, 3, 6, & 12 months

  4. Frequency of Pain Medication Use

    Assesses the frequency and type of pain medication administered to participants at baseline and follow-up visits scheduled at 1, 3, 6, and 12 months. Data will be collected to track changes in pain medication usage over time.

    Time frame: 1, 3, 6, & 12 months

08

Study locations

24 sites
  • Mocek Spine
    Little Rock, Arkansas 72205, United States
  • MD Pain
    Englewood, Colorado 80112, United States
  • Western Rockies Interventional Pain
    Grand Junction, Colorado 81505, United States
  • Premier Spine and Pain Institute
    Thornton, Colorado 80229, United States
  • The Orthopedic Institute
    Gainesville, Florida 32605, United States
  • Raso Pain Center
    Jupiter, Florida 33477, United States
  • Interventional Spine Care of the Palm Beaches
    West Palm Beach, Florida 33407, United States
  • Horizon Clinical Research
    Jasper, Georgia 30143, United States
  • The Orthopedic Research Foundation, Inc.
    Fishers, Indiana 46278, United States
  • Interventional Pain Specialists - Pain Clinic
    Opelousas, Louisiana 70570, United States
  • Paradigm Health System
    Slidell, Louisiana 70461, United States
  • Premier Pain Solutions
    Asheville, North Carolina 28803, United States
  • Comprehensive Pain Consultants of the Carolinas
    Hendersonville, North Carolina 28791, United States
  • Crystal Coast Pain Management
    Morehead City, North Carolina 28557, United States
  • Crystal Coast Pain Management
    New Bern, North Carolina 28560, United States
  • Align Interventional Pain
    Edmond, Oklahoma 73013, United States
  • Atlantic Coast Spine & Pain
    Conway, South Carolina 29526, United States
  • Renew Pain Solutions
    Greenville, South Carolina 29607, United States
  • Specialists in Pain Managment
    Chattanooga, Tennessee 37404, United States
  • Freedom Spine
    Boerne, Texas 78006, United States
  • Corpus Chrisi Pain Medicine
    Corpus Christi, Texas 78415, United States
  • Advanced Spine and Pain Center
    San Antonio, Texas 78240, United States
  • Pain and Wellness Institute of Texas
    Spring Branch, Texas 80700, United States
  • Precision Spine Care
    Tyler, Texas 75701, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Jan 2027, 34 months after the start.

Of 187 observational studies under Low Back Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's planned 34 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2024
First posted
Apr 3, 2024
StartActual
Feb 27, 2024
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 1, 2027
Last update
May 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06345690
Lead sponsor
VIVEX Biologics, Inc.
Responsible party
Sponsor
First posted
Apr 3, 2024
Start date
Feb 27, 2024
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
May 12, 2026

Study contacts

Leslie Zaccari
study director · Sponsor - Vivex Biologics

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion